(Q37564522)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637980%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

review article

1 reference

title

Therapeutic peptides for cancer therapy. Part I - peptide inhibitors of signal transduction cascades (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637980%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637980%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Drazen Raucher

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637980%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

language of work or name

English

0 references

publication date

1 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637980%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Delivery

3 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637980%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637980%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637980%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

1033-1047

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637980%20AND%20SRC:MED&resulttype=core&format=json

Transmembrane transport of peptide type compounds: prospects for oral delivery

3 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

TAT peptide internalization: seeking the mechanism of entry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Cellular utake of the Tat peptide: an endocytosis mechanism following ionic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

A brief introduction to cell-penetrating peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

The many roads that lead to Ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Complexes of p21RAS with JUN N-terminal kinase and JUN proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Identification of the site of inhibition of oncogenic ras-p21-induced signal transduction by a peptide from a ras effector domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

In vitro inhibition of Ras-Raf association by short peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Peptides designed from molecular modeling studies of the ras-p21 protein induce phenotypic reversion of a pancreatic carcinoma cell line but have no effect on normal pancreatic acinar cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Two peptides derived from ras-p21 induce either phenotypic reversion or tumor cell necrosis of ras-transformed human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the guanine-nucleotide exchange protein, SOS, identified from molecular dynamics calculations. Selective inhibition of oncogenic ras-p21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Comparison of the average structures, from molecular dynamics, of complexes of GTPase activating protein (GAP) with oncogenic and wild-type ras-p21: identification of potential effector domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Inhibition of ras-induced oocyte maturation by peptides from ras-p21 and GTPase activating protein (GAP) identified as being effector domains from molecular dynamics calculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the ras-binding domain of the raf-p74 protein, identified from molecular dynamics calculations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Peptides containing a consensus Ras binding sequence from Raf-1 and theGTPase activating protein NF1 inhibit Ras function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

An alternative to phosphotyrosine-containing motifs for binding to an SH2 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Tetrapeptide inhibitors of protein farnesyltransferase: amino-terminal substitution in phenylalanine-containing tetrapeptides restores farnesylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Inhibitors of protein farnesyltransferase as novel anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Farnesyltransferase inhibitors: a detailed chemical view on an elusive biological problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Regulation of transcription by MAP kinase cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Selective in vivo inhibition of mitogen-activated protein kinase activation using cell-permeable peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Regulation of JNK signaling by GSTp

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

An effector peptide from glutathione-S-transferase-pi strongly and selectively blocks mitotic signaling by oncogenic ras-p21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Identification of the critical features of a small peptide inhibitor of JNK activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Therapeutic promise of JNK ATP-noncompetitive inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Peptide inhibitors of protein kinases-discovery, characterisation and use

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Inhibitors of c-Jun N-terminal kinases: JuNK no more?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Shared principles in NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Antineuroinflammatory effect of NF-kappaB essential modifier-binding domain peptides in the adoptive transfer model of experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Amelioration of acute inflammation by systemic administration of a cell-permeable peptide inhibitor of NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Protection of islets by in situ peptide-mediated transduction of the Ikappa B kinase inhibitor Nemo-binding domain peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Selective targeting of the nuclear factor-kappaB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Inhibition of the canonical IKK/NF kappa B pathway sensitizes human cancer cells to doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

NEMO-binding domain peptide inhibits proliferation of human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

The trimerization domain of NEMO is composed of the interacting C-terminal CC2 and LZ coiled-coil subdomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Inhibition of NF-kappa B activation by peptides targeting NF-kappa B essential modulator (nemo) oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

A nuclear import inhibitory peptide ameliorates the severity of cholecystokinin-induced acute pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-kappaB, in treatment of corneal alkali burns in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Constitutive nuclear factor-kappaB activity is crucial for human retinoblastoma cell viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Inhibition of nuclear factor-kappaB cascade potentiates the effect of a combination treatment of anaplastic thyroid cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

SN52, a novel nuclear factor-kappaB inhibitor, blocks nuclear import of RelB:p52 dimer and sensitizes prostate cancer cells to ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

A D-amino acid peptide inhibitor of NF-kappa B nuclear localization is efficacious in models of inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Small peptides activate the latent sequence-specific DNA binding function of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Reactivation of mutant p53 through interaction of a C-terminal peptide with the core domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Correlation between hydrophobic properties and efficiency of carrier-mediated membrane transduction and apoptosis of a p53 C-terminal peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Selective induction of apoptosis through the FADD/caspase-8 pathway by a p53 c-terminal peptide in human pre-malignant and malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

A peptide that binds and stabilizes p53 core domain: chaperone strategy for rescue of oncogenic mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Rescue of mutants of the tumor suppressor p53 in cancer cells by a designed peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

The penetratin sequence in the anticancer PNC-28 peptide causes tumor cell necrosis rather than apoptosis of human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

PNC-28, a p53-derived peptide that is cytotoxic to cancer cells, blocks pancreatic cancer cell growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Transducible peptide therapy for uveal melanoma and retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

c-MYC: more than just a matter of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Myc and Max associate in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Thermal cycling enhances the accumulation of a temperature-sensitive biopolymer in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Enhancing the antiproliferative effect of topoisomerase II inhibitors using a polypeptide inhibitor of c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Targeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Peptide and protein drug delivery to and into tumors: challenges and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Anticancer carrier-linked prodrugs in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

Stimulus-responsive "smart" hydrogels as novel drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745

A stimulus-responsive magnetic nanoparticle drug carrier: magnetite encapsulated by chitosan-grafted-copolymer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903143745